Back to Search Start Over

ALSUntangled #68: ozone therapy

Authors :
Yuyao Sun
Paul Barkhaus
Benjamin Barnes
Morgan Beauchamp
Michael Benatar
Tulio Bertorini
Mark Bromberg
Gregory T. Carter
Jesse Crayle
Merit Cudkowicz
Mazen Dimachkie
Eva L. Feldman
Timothy Fullam
Terry Heiman-Patterson
Sartaj Jhooty
Isaac Lund
Christopher Mcdermott
Gary Pattee
Kaitlyn Pierce
Dylan Ratner
Paul Wicks
Richard Bedlack
Source :
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. :1-5
Publication Year :
2022
Publisher :
Informa UK Limited, 2022.

Abstract

ALSUntangled reviews alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS). Here we review ozone therapy. Ozone therapy has possible mechanisms for slowing ALS progression based on its antioxidant, anti-inflammatory, and mitochondrial effects. A non-peer-reviewed report suggests that ozone treatment may slow progression in a mTDP-43 mouse model of ALS. One verified "ALS reversal" occurred on a cocktail of alternative treatments including ozone. There are no ALS trials using ozone to treat PALS. There can be potentially serious side effects associated with ozone therapy, depending on the dose. Based on the above information, we support an investigation of ozone therapy in ALS cell or animal models but cannot yet recommend it as a treatment in PALS.

Subjects

Subjects :
Neurology
Neurology (clinical)

Details

ISSN :
21679223 and 21678421
Database :
OpenAIRE
Journal :
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Accession number :
edsair.doi.dedup.....3a1e944d0054c11e176d97af22e1e825